CID 16130390

Monopalmitoyl propylene diamine conjugated disonucleotide(p-ctccgcttct)

Structural Information

Molecular Formula
C114H164N30O65P10
SMILES
CCCCCCCCCCCCCCCC(=O)NCCCNP(=O)(O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OP(=O)(O)OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=O)(O)OCC5C(CC(O5)N6C=CC(=NC6=O)N)OP(=O)(O)OCC7C(CC(O7)N8C=CC(=NC8=O)N)OP(=O)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C114H164N30O65P10/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-20-87(146)121-26-19-27-123-210(161,162)181-48-73-63(34-89(192-73)135-28-21-82(115)124-106(135)152)201-212(165,166)187-53-78-68(39-94(197-78)141-44-59(3)101(148)132-112(141)158)206-217(175,176)185-51-76-65(36-91(195-76)137-30-23-84(117)126-108(137)154)203-213(167,168)183-50-75-67(38-93(194-75)139-32-25-86(119)128-110(139)156)205-215(171,172)190-56-81-71(42-97(200-81)144-57-122-98-99(144)129-105(120)130-104(98)151)209-219(179,180)186-52-77-66(37-92(196-77)138-31-24-85(118)127-109(138)155)204-214(169,170)188-54-79-70(41-96(198-79)143-46-61(5)103(150)134-114(143)160)208-218(177,178)189-55-80-69(40-95(199-80)142-45-60(4)102(149)133-113(142)159)207-216(173,174)184-49-74-64(35-90(193-74)136-29-22-83(116)125-107(136)153)202-211(163,164)182-47-72-62(145)33-88(191-72)140-43-58(2)100(147)131-111(140)157/h21-25,28-32,43-46,57,62-81,88-97,145H,6-20,26-27,33-42,47-56H2,1-5H3,(H,121,146)(H,163,164)(H,165,166)(H,167,168)(H,169,170)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H,179,180)(H2,115,124,152)(H2,116,125,153)(H2,117,126,154)(H2,118,127,155)(H2,119,128,156)(H2,123,161,162)(H,131,147,157)(H,132,148,158)(H,133,149,159)(H,134,150,160)(H3,120,129,130,151)
InChIKey
UFLOJVJKDATHKZ-UHFFFAOYSA-N
Compound name
[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[[3-[[3-[[5-(4-amino-2-oxopyrimidin-1-yl)-3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-N-[3-(hexadecanoylamino)propyl]phosphonamidic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3302.7827 Da
Monoisotopic Mass

-14.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3303.7900 296.0
[M+Na]+ 3325.7719 301.7
[M-H]- 3301.7754 299.9
[M+NH4]+ 3320.8165 298.2
[M+K]+ 3341.7459 297.8
[M+H-H2O]+ 3285.7800 294.0
[M+HCOO]- 3347.7809 298.2
[M+CH3COO]- 3361.7966 298.5
[M+Na-2H]- 3323.7574 308.7
[M]+ 3302.7822 294.9
[M]- 3302.7832 294.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.